Ogoina Dimie, Adekunle Victor, Obiako Reginald, Umar Abdulaziz, Akolawole Michael, Ovosi Joseph
Department of Medicine, Bingham University Teaching Hospital, Jos, Plateau state, Nigeria.
Pan Afr Med J. 2011;9:38. doi: 10.4314/pamj.v9i1.71216. Epub 2011 Aug 16.
Immune Reconstitution Inflammatory Syndromes (IRIS) are exaggerated pathological inflammatory reactions occurring after initiation of highly active antiretroviral therapy (HAART) due to exuberant immune responses to occult or apparent opportunistic infections or cancers. In view of paucity of studies from Nigeria, we report 3 cases of IRIS presenting as disseminated infections in HIV-1 infected patients initiating HAART. The first case was a previously healthy female who developed disseminated tuberculosis after 4 weeks of regular HAART. Her HAART regimen was continued and she improved after commencement of anti-tuberculosis drugs, with evidence of progressive increase in CD4 cell count. The second case was a HAART-experienced female who stopped her drugs for 4 months. Two months after recommencement of her previous HAART regimen, she developed features of disseminated herpes zoster infection, despite evidence of decrease in viral load by 95%. HAART was continued and she recovered completely after receiving valaciclovir tablets and antibiotics. The third patient was a female student who was commenced HAART on account of chronic cough and weight loss. Three months after regular HAART, she developed features of disseminated Kaposi's sarcoma involving the skin, oropharynx and lungs, despite evidence of 42% increase in CD4 cell count. Unfortunately, she rapidly deteriorated and died during the course of management. Clinicians should be alert to the possibility of IRIS in HIV-infected patients initiated or re-initiated on HAART. There is need for future prospective studies determining risk factors for IRIS in HIV-infected patients from Nigeria.
免疫重建炎症综合征(IRIS)是在开始高效抗逆转录病毒治疗(HAART)后发生的过度病理性炎症反应,这是由于对隐匿性或明显的机会性感染或癌症产生了旺盛的免疫反应。鉴于来自尼日利亚的研究较少,我们报告了3例在开始HAART的HIV-1感染患者中表现为播散性感染的IRIS病例。第一例是一名先前健康的女性,在规律HAART治疗4周后发生播散性结核病。她继续接受HAART治疗,在开始抗结核药物治疗后病情改善,CD4细胞计数有逐渐增加的迹象。第二例是一名有HAART治疗经验的女性,她停用药物4个月。在重新开始之前的HAART治疗方案两个月后,尽管病毒载量下降了95%,但她出现了播散性带状疱疹感染的症状。继续进行HAART治疗,在接受伐昔洛韦片和抗生素治疗后她完全康复。第三例患者是一名女学生,因慢性咳嗽和体重减轻开始接受HAART治疗。在规律HAART治疗3个月后,尽管CD4细胞计数增加了42%,但她出现了累及皮肤、口咽和肺部的播散性卡波西肉瘤的症状。不幸的是,她在治疗过程中迅速恶化并死亡。临床医生应对开始或重新开始HAART治疗的HIV感染患者发生IRIS的可能性保持警惕。有必要进行未来的前瞻性研究,以确定尼日利亚HIV感染患者发生IRIS的危险因素。